Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Reneo Pharmaceuticals (RPHM)
NASDAQ:RPHM
RESEARCH TOOLSreports
Reneo Pharmaceuticals (RPHM) Ownership - Who Owns Reneo Pharmaceuticals?
226 Followers
Reneo Pharmaceuticals (RPHM) Ownership Overview
58.05% Insiders
12.37% Mutual Funds
3.37% Other Institutional Investors
26.20% Public Companies and
Individual Investors
The ownership structure of Reneo Pharmaceuticals (RPHM) stock is a mix of institutional, retail and individual investors. Approximately 15.75% of the company’s stock is owned by Institutional Investors, 58.05% is owned by Insiders and 26.20% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 16, 2024 | Braden Michael Leonard >10% Owner | xxxxxxxxxxxxx | $639578 |
| Aug 29, 2023 | Ashley Hall Cdo | xxxxxxxxxxxxx | $97969 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $4542706 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,736,570 | Institution | 8.19% | 4,050,124 | |
| 2,078,142 | Institution | 6.22% | 3,075,650 | |
| 886,075 | Institution | 2.65% | 1,311,391 | |
| 878,772 | Institution | 2.63% | 1,300,583 | |
| 874,654 | Institution | 2.62% | 1,294,488 | |
| 473,833 | Institution | 1.42% | 701,273 | |
| 450,646 | Institution | 1.35% | 666,956 | |
| 241,859 | Institution | 0.72% | 357,951 | |
| 181,247 | Institution | 0.54% | 268,246 | |
| 127,395 | Institution | 0.38% | 188,545 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,078,142 | Institution | 6.22% | 3,075,650 | |
| 874,654 | Institution | 2.62% | 1,294,488 | |
| 473,833 | Institution | 1.42% | 701,273 | |
| 181,247 | Institution | 0.54% | 268,246 | |
| 127,395 | Institution | 0.38% | 188,545 | |
| 91,380 | Institution | 0.27% | 135,242 | |
| 60,000 | Institution | 0.18% | 88,800 | |
| 59,369 | Institution | 0.18% | 87,866 | |
| 37,503 | Institution | 0.11% | 55,504 | |
| 30,807 | Institution | 0.09% | 45,594 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 596,113 | Institution | 1.78% | 900,131 | |
| 278,541 | Institution | 0.83% | 420,597 | |
| 149,916 | Institution | 0.45% | 221,876 | |
| 45,513 | Institution | 0.14% | 67,359 | |
| 23,215 | Institution | 0.07% | 34,126 | |
| 1,895 | Institution | <0.01% | 14,042 | |
| 4,118 | Institution | 0.01% | 6,218 | |
| 1,165 | Institution | <0.01% | 1,724 |
FAQ
Who Owns Reneo Pharmaceuticals (RPHM)?
According to the latest TipRanks data, approximately 3.37% of the company's stock is held by institutional investors, 58.05% is held by insiders, and 26.20% is held by retail investors.
What percentage of Reneo Pharmaceuticals (RPHM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.37% of Reneo Pharmaceuticals (RPHM) stock is held by institutional investors.
What percentage of Reneo Pharmaceuticals (RPHM) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.20% of Reneo Pharmaceuticals (RPHM) stock is held by retail investors.
Who owns the most shares of Reneo Pharmaceuticals (RPHM)?
Scott Kapnick owns the most shares of Reneo Pharmaceuticals (RPHM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.